ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Ann Thorac Surg 2008;85:1655. doi:10.1016/j.athoracsur.2008.02.059
© 2008 The Society of Thoracic Surgeons
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Butterworth, J.
PubMed
Right arrow Articles by Butterworth, J.
Related Collections
Right arrow Cardiac - pharmacology
Right arrowRelated Article

Original Articles: Adult Cardiac

Invited Commentary

John Butterworth, MD

Department of Anesthesia, Indiana University School of Medicine, 204 South Dr, FH 204, Indianapolis, IN 46202

(Email: jfbutter@iupui.edu).

The first 20% of the full text of this article appears below.

Unfractionated heparin, first purified, named, and used in experimental surgery in the first quarter of the 20th century, remains an extraordinarily versatile drug when temporary and profound degrees of anticoagulation are needed [1]. Unfortunately, prolonged or repeated exposure to unfractionated heparin, increasingly common . . . [Full Text of this Article]


Related Article

Argatroban as a Primary or Secondary Postoperative Anticoagulant in Patients Implanted With Ventricular Assist Devices
Louis E. Samuels, Jaromir Kohout, Elena Casanova-Ghosh, Kevin Hagan, Phil Garwood, Francis Ferdinand, and Scott M. Goldman
Ann. Thorac. Surg. 2008 85: 1651-1655. [Abstract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The Society of Thoracic Surgeons.